clinical trial · NCT07400536
A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·phase3·recruiting·n = 378
Locally Advanced Cervical Carcinomastandard EBRT+BrachytherapyConcurrent chemotherapyImmune induction therapyReduced dose radiotherapyDose reduction concurrent chemotherapyImmunomaintenance therapy
brief summary
This study mainly evaluated the efficacy and safety of Cadonilimab combined with chemotherapy followed by concurrent chemoradiotherapy versus standard concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer.
started
Apr 24, 2026
primary completion
Jul 18, 2028
completion
Jul 20, 2032
last updated
May 13, 2026
official title
A Phase III, Multicenter, Open-label, Randomized Controlled Clinical Study on the Treatment of Locally Advanced Cervical Cancer With Cadonilimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol